Objectives:
1. Understand state of art treatment of sickle cell disease symptomology
2. Effective use of hydroxyurea for reduction of vaso-occlusive crises
3. Role of transplantation for cure of sickle cell disease
Session date:
02/09/2017 - 8:30am to 9:00am CST
Location:
Little Company of Mary Hospital
Evergreen Park, IL
60805
United States
See map: Google Maps
Add to calendar:
- 0.50 AMA PRA Category 1 Credit™
- 0.50 Participation
Speaker Name:
John Cunningham, MD MRCP